Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Anti-fibrotic activity refers to the ability to prevent, reduce, or reverse fibrosis—the pathological accumulation of extracellular matrix (ECM) components that leads to tissue scarring and organ dysfunction. It targets pathways involved in myofibroblast activation, collagen synthesis, and inflammation to halt or reverse fibrogenesis.
Blockade/inhibition of cytokine signaling; suppression of collagen synthesis/fibrillogenesis; autophagy induction
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Anti-fibrotic Activity.